Post-approval studies (Phase 4)Looking for participantsNCT07704658
What this trial is testing
Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Thyroid CancerSolid Tumor Malignancies+1 more
Rigel Pharmaceuticals 12